Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
BPC-157 has been widely studied in preclinical models for its potential role in: Tissue regeneration research (muscle, tendon, and epithelial cells), Gastrointestinal studies, exploring protective effects on gut lining and gastric integrity, Angiogenesis and vascular modulation research, Neuroprotective and anti-inflammatory investigations, These findings support continued interest in understanding BPC-157s interaction with cellular growth and repair pathways in experimental contexts
It helps to improve the safety and reliability of experimental results
The Hudson Biotech NCT07437547 Phase 2 hamstring trial (recruiting February 2026, n=120 estimated) is the first registered acute-muscle-injury efficacy trial of BPC-157 [7]
10 Centers for Disease Control and Prevention (CDC)Subcutaneous injection technique: angle, site and no-aspiration guidance
US$ 24.37
US$ 22.79
US$ 25.78
US$ 24.13
US$ 29.61
US$ 25.28
US$ 22.43
US$ 27.75
US$ 27.41
US$ 29.01
